07 Jan 2001

Lonarid® (Lonarid® Tabletten) - Deutschland

Updated: 07 Jan 2001

Lonarid®

Mittelstarke bis starke Schmerzen. Für Erw. und Jugendl.

Lonarid® Description, Presentation and Dosage

Lonarid® Description

Lonarid® Drug Class Description

Kombinationen mit Codein u. -Derivaten

Lonarid® Drug Description

1 Tbl. enth.: Paracetamol 500 mg, Codeinphosphat ½H2O 30 mg.

Lonarid® Generic Name

Lonarid® Tabletten

Lonarid® Presentation

Lonarid® Presentation

Lonarid®

Lonarid® Manufacturer

Boehringer Ingelheim

Related Learning Zones

CLL Knowledge Centre and CME

CLL Knowledge Centre and CME

The Chronic Lymphocytic Leukaemia (CLL) Knowledge Centre contains useful information arranged within four main sections: ‘Disease Awareness’, ‘Events’, ‘Resources’, and 'CME'. Healthcare professionals will find information on pathophysiology, signs and symptoms of CLL, diagnosis, prognosis, treatment and management options, an upcoming events calendar and an external links listing,

The CME activity ‘Treatment Optimisation in Chronic Lymphocytic Leukaemia’ has been EACCME-accredited and awarded 1 CME credit. Test your knowledge by answering quiz questions based on patient case study scenarios.

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis is intended for healthcare professionals involved in the treatment and management of patients with psoriasis. This resource has been developed primarily to discuss the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A. Users can expect to find sections containing expert videos, clinical slide decks, congress highlights, key publications and links to useful resources.

This resource has been developed in collaboration with Novartis Pharma AG.

Lonarid® Dosage

Lonarid® Adult Dosage

Cellulose, Carmellose-Natrium, Ethylcellulose, Maisstärke, Siliciumdioxid, Magnesiumstearat.

Lonarid® Precautions, Reactions and Contraindications

Lonarid® Special Precautions

Lonarid® Special Precautions

C 85. Krankheitszustände, bei denen eine Dämpfung des Atemzentrums vermieden werden muß. Kdr. unter 14 J.

Lonarid® Adverse Reactions

Lonarid® Adverse Reactions

C 85, P 5

Related Drugs - Pain Management

Back to top